| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 454 | 449 | 3.246 | 1.934 | 3.161 | 2.481 | 2.426 | 2.433 | 0 | 0 |
| Total Income - EUR | 454 | 449 | 3.246 | 1.934 | 3.161 | 2.481 | 2.426 | 2.433 | 0 | 0 |
| Total Expenses - EUR | 438 | 380 | 2.606 | 54 | 22 | 1.021 | 191 | 2.728 | 1.209 | 0 |
| Gross Profit/Loss - EUR | 16 | 69 | 641 | 1.880 | 3.139 | 1.460 | 2.235 | -295 | -1.209 | 0 |
| Net Profit/Loss - EUR | 2 | 56 | 543 | 1.822 | 3.044 | 1.388 | 2.162 | -368 | -1.209 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Doximil Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.619 | 4.664 | 2.309 | 4.070 | 7.054 | 7.225 | 9.227 | 1.213 | 0 | 40 |
| Inventories | 3.356 | 3.335 | 1.053 | 1.033 | 1.013 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.262 | 1.326 | 1.254 | 1.241 | 1.221 | 1.203 | 1.205 | 1.213 | 0 | 0 |
| Cash | 1 | 4 | 3 | 1.795 | 4.820 | 6.022 | 8.022 | 0 | 0 | 40 |
| Shareholders Funds | 560 | 610 | 1.143 | 2.944 | 5.931 | 7.207 | 9.209 | 1.164 | -48 | -8 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.059 | 4.054 | 1.166 | 1.126 | 1.123 | 19 | 18 | 48 | 48 | 48 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Doximil Impex S.r.l.